Actionable news
0
All posts from Actionable news
Actionable news in CEMP: Cempra, Inc.,

Cempra to Present Solithromycin IV Data at ATS 2016

CHAPEL HILL, N.C., May 12, 2016 (GLOBE NEWSWIRE via COMTEX) --

Cempra, Inc. CEMP, -0.54% a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced it will be participating in the American Thoracic Society (ATS) International Conference 2016, May 13-18, to be held in San Francisco.

Presentation at ATS 2016:

  • SOLITAIRE-IV: Results of a Phase 3 IV to Oral Trial in Adults with Community-acquired Bacterial Pneumonia comparing Solithromycin to Moxifloxacin - A62. Clinical Aspects of CAP, HCAP, HAP, and VAP, Poster #P840, Moscone Center, Area G, Hall D (North Building, Lower Level), May 15, 11:00 a.m. PDT. An abstract is available using the link Solithromycin ATS 2016.

About Cempra, Inc.

Cempra, Inc. is a...


More